Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Family Medicine
•
Primary Care
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Answer from: at Community Practice
6 months
Sign In
or
Register
to read more
21202
Related Questions
How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?
Do you recommend structured Tai Chi for patients with osteopenia and osteoporosis?
For patients <65 with significant intermittent steroid exposure who otherwise do not have risk factors for osteoporosis, when, if ever, do you recommend considering DEXA screening?
How do you approach osteoporosis screening in men?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
In adults ≥80 years with TSH 6–10 mIU/L and minimal symptoms, do you initiate levothyroxine, monitor, or avoid treatment entirely?
When do you think about using orforglipron relative to tirzepatide or other GLP-1s when weight loss is the main goal in a patient with type 2 diabetes and obesity?
How do you decide between lifestyle therapy alone and immediate statin initiation in a younger adult with LDL-C 70-189 mg/dL and PREVENT risk above 3%?
How do you discuss the importance of ongoing lifestyle-based interventions when starting a GLP-1 agonist for medically relevant obesity (i.e., with comorbid conditions)?
What are the clinical prompts that lead you to consider deprescribing bisphosphonate therapy in older adults with osteoporosis?